Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion type Assertion NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_head.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion description "[Positive expression for both p53 and p21 puts patients with bladder CIS at the greatest risk of bladder cancer recurrence, progression, and, most importantly, mortality, suggesting a potential rationale for early definitive therapy in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_provenance.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion evidence source_evidence_literature NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_provenance.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion SIO_000772 12809883 NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_provenance.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion wasDerivedFrom befree-2016 NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_provenance.
- NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_assertion wasGeneratedBy ECO_0000203 NP398272.RAKODBKqNF2n1U-AqMLvyVvewlAL6qKhhf-P_d7TeObng130_provenance.